Related Experiment Video
Updated: Dec 20, 2025

Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity
Published on: August 23, 2022
Characterising lipoteichoic acid as an in vitro model of acute neuroinflammation
Anne-Marie Howe1, Aoife Cosgrave1, Maitiú Ó'Murchú1
1UCD School of Biomolecular & Biomedical Science, UCD Conway Institute, University College Dublin, Ireland.
Abstract:
Toll-like receptor 2 (TLR2) is a primary sensor for pathogens, including those derived from gram-positive bacteria. It can also mediate the effects of endogenous inflammatory signals such as β-amyloid peptide (Aβ), thus promoting the microglial activation and subsequent neuronal dysfunction, characteristic of chronic neuroinflammatory conditions. More recently, a role for TLR2 has been proposed in the pathogenesis of disorders associated with acute inflammation, including anxiety and depression. The current study aims to characterise the acute effects of the TLR2 agonist lipoteichoic acid (LTA) on microglial activation and neuronal integrity, and to evaluate the influence of LTA exposure on sensitivity to the inflammation and neuronal dysfunction associated with Aβ. Using BV2 and N2a cells as an in vitro model, we highlight that acute exposure to LTA robustly promotes inflammatory cytokine and nitric oxide (NO) production in microglia but also in neurons, similar to that reported under longer-term and chronic inflammatory conditions. Moreover, we find that exposure to LTA can enhance sensitivity to subthreshold Aβ, promoting an 'M1'-like phenotype in microglia and provoking dysregulation of neuronal activity in acute hippocampal slices. Anti-inflammatory agents, including mimetics of brain-derived neurotrophic factor (BDNF), have proven effective at alleviating chronic neuroinflammatory complications. We further examined the effects of 7,8,3-trihydroxyflavone (7,8,3-THF), a small-molecule TrkB agonist, on LTA-induced microglial activation. We report that 7,8,3-THF can significantly ameliorate interleukin (IL)-6 and NO production in LTA-stimulated BV2 cells. Taken together, our findings offer support for exploration of TLR2 as a potential target for therapeutic intervention into acute neuroinflammatory conditions. Moreover we propose that exposure to gram-positive bacterial pathogens may promote sensitivity to the inflammatory changes characteristic of the aged brain.
Insights
Toll-like receptor 2 (TLR2) activation by lipoteichoic acid (LTA) triggers acute neuroinflammation and primes neurons for amyloid-beta (Aβ) effects. A TrkB agonist, 7,8,3-trihydroxyflavone (7,8,3-THF), mitigates these inflammatory responses.
Area of Science:
- Neuroimmunology
- Microbial Pathogenesis
- Neuroinflammation
Background:
- Toll-like receptor 2 (TLR2) senses pathogens and endogenous signals like amyloid-beta (Aβ).
- TLR2 activation contributes to neuroinflammation, microglial activation, and neuronal dysfunction.
- Emerging evidence links TLR2 to acute inflammatory disorders such as anxiety and depression.
Purpose of the Study:
- To characterize acute lipoteichoic acid (LTA) effects on microglial activation and neuronal integrity.
- To assess LTA's influence on Aβ-induced inflammation and neuronal dysfunction.
- To investigate the therapeutic potential of 7,8,3-trihydroxyflavone (7,8,3-THF) against LTA-induced neuroinflammation.
Main Methods:
- In vitro studies using BV2 (microglia) and N2a (neuron) cell lines.
- Acute hippocampal slice electrophysiology to assess neuronal activity.
- Treatment with LTA, Aβ, and 7,8,3-THF, a TrkB agonist.
Main Results:
- Acute LTA exposure induced inflammatory cytokine and nitric oxide (NO) production in both microglia and neurons.
- LTA exposure enhanced microglial sensitivity to Aβ, promoting an M1-like phenotype and neuronal dysregulation.
- 7,8,3-THF significantly reduced LTA-induced interleukin-6 (IL-6) and NO production.
Conclusions:
- Acute TLR2 activation by LTA drives neuroinflammation and primes neuronal sensitivity to Aβ.
- TLR2 represents a potential therapeutic target for acute neuroinflammatory conditions.
- Gram-positive bacterial exposure may increase susceptibility to age-related neuroinflammation.

